Dengue Virus Serotype 1 VLP Recombinant Protein Product Attributes
Product Type: Recombinant Protein
Recombinant Dengue Virus Serotype 1 VLP based upon sequence from: Dengue virus (Strain: Puerto Rico/US/BID-V1053/1998). This VLP protein is combinantion of the C, E1 and E2 sequences. Virus-Like Particles (VLPs) are a new form of protein expression that consist of protein shells with outer proteins that are specific to the given virus. VLPs are immunogenic but are non-infectious, lacking the primary genetic material of the virus. Additionally, VLPs more effectively activate aspects of the immune response, which improves immune stimulation and immunological memory. VLP-based vaccines have also shown to provide effective protection and are in current use for several diseases.
Isolation Country: Puerto Rico
NCBI Taxonomic Identifier: Not assigned
Taxonomy: Flaviviridae -> Flavivirus -> Dengue virus
VIPR Database Entry: DENV-1 Strain-Specific Entry
VLP Protein CDS Start-End: C: 1-286; E1: 827-2311; E2:N/A
DENV-1 Protein Sequence: See above
Host: QP10476 protein expressed in Human Cells.
Application Notes: Please contact us for application specific information for QP10476.
Purity: >95% as determined by SDS-PAGE.
Reconstitution Instructions:Reconstitute in sterile diH2O. The lyophilate already contains the indicated buffer.
Concentration of Dengue Virus Serotype 1, DENV-1 VLP Protein: 0.1 - 07 mg/ml
Endotoxin Levels: Untested
Buffer: 10mM sodium phosphate, 20mM sodium citrate, 154mM sodium chloride, pH7.4.
Storage Conditions: Aliquot and store at -80C.
Limitations and Performance Guarantee
This is a life science research product (for Research Use Only). This product is guaranteed to work for a period of two years when stored at -70C or colder, and one year when aliquoted and stored at -20C.